发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
BACKGROUND:The use of bioprostheses for surgical aortic valve replacement increased substantially within the last years. In case of prosthesis failure, re-SAVR is standard of care, whereas valve-in-valve deployment of a transfemoral transcatheter aortic valve prosthesis (VinV-TFAVI) has recently emerged as an alternative. We sought to evaluate early safety, clinical efficacy, and all-cause 1-year-mortality of VinV-TFAVI and redo surgery for failing aortic bioprostheses (re-SAVR). METHODS AND RESULTS:Patients receiving either VinV-TFAVI (n = 147) or re-SAVR (n = 111) for a degenerated aortic bioprosthesis between 01/2006 and 05/2017 were included in this analysis. All-cause 1-year mortality was the primary outcome measure. Early safety and clinical efficacy according to VARC-2 endpoint definitions were evaluated at 30 days. Baseline characteristics differed significantly between both groups including age, STS-PROM, and incidence of relevant comorbidities. Re-stenosis was the predominant mode of failure in 45.9% of re-SAVR and 63.1% of VinV-TFAVI patients. The rate of "early safety" endpoints was lower with VinV-TFAVI (17.7% vs. 64.9%, p < 0.01), the rate of "clinical efficacy" endpoints was lower, e.g. better with re-SAVR (53.1% vs. 32.4%, p < 0.01). All-cause 1-year-mortality (VinV-TFAVI 8.8% vs re-SAVR 9.9%, p = 0.84) was not different. Treatment strategy was not associated with 1-year-mortality in a Cox regression analysis. The incidence of prosthesis-patient-mismatch was higher in VinV-TFAVI compared to re-SAVR. CONCLUSION:VinV-TFAVI represents a viable alternative for treatment of degenerated aortic bioprostheses in patients at increased surgical risk. However, in patients at low risk for reoperation, a better clinical efficacy and acceptable safety may favour re-SAVR.
展开更多
最新影响因子:4.039 | 期刊ISSN:0167-5273 | CiteScore:1.76 |
出版周期:Semimonthly | 是否OA:YES | 出版年份:1981 |
期刊官方网址:http://www.elsevier.com/wps/find/journaldescription.cws_home/506041/description#description
期刊投稿地址:http://ees.elsevier.com/ijc/
自引率:8.80% | 研究方向:医学-心血管系统 |
出版地区:IRELAND |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
The International Journal of Cardiology is devoted to cardiology in the broadest sense. Both basic research and clinical papers can be submitted. The journal serves the interest of both practicing clinicians and research workers.Editorials, Brief Reports and Review Articles covering recent developments are included. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.International Journal of Cardiology has no page charges.A reduced personal subscription rate is available; please apply to the Publisher for more information.
《国际心脏病学杂志》在最广泛的意义上致力于心脏病学。基础研究和临床论文都可以提交。该杂志为临床医师和研究工作者提供了服务,包括社论、简要报告和评论文章。讨论有争议的技术、健康政策和社会医学问题,并作为鼓励辩论的有用工具。国际心脏病杂志不收取页面费用。可降低个人订阅率;请向出版商申请了解更多信息。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
CARDIAC & CARDIOVASCULAR SYSTEMS (心脏和心血管系统) 3区 |
41/128 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
1199 | 1085 | 114 |
引文计数(2018)
文献(2015-2017)
11795次引用
6683篇文献
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Medicine
小类(学科):Cardiology and Cardiovascular Medicine
|
#113/327
点击查看排名表
|
|
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
15年经验沉淀,实体公司
运营
liting7111
研究方向:医学 儿科
审稿时间: 6个月内
liting7111
liting7111
研究方向:抗凝 抗栓 药物基因组学
审稿时间: 2个月内 接受率: 比较困难(25%命中)
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
审稿时间: 2个月内 接受率: 比较困难(25%命中)
liting7111
审稿时间: 3个月内
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
审稿时间: 2个月内 接受率: 比较困难(25%命中)
liting7111
审稿时间: 3个月内 接受率: 中等(50%命中)
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
liting7111
影响因子:1.992
ISSN:1976-1457
研究方向:NUTRITION & DIETETICS-
影响因子:1
ISSN:0139-3006
研究方向:农林科学-食品科技
影响因子:3.221
ISSN:1654-6628
研究方向:FOOD SCIENCE & TECHNOLOGY-NUTRITION & DIETETICS
影响因子:9.298
ISSN:1930-7381
研究方向:医学-内分泌学与代谢
影响因子:4.807
ISSN:1662-4025
研究方向:医学-内分泌学与代谢
影响因子:4.725
ISSN:2044-4052
研究方向:ENDOCRINOLOGY & METABOLISM-NUTRITION & DIETETICS
影响因子:1.417
ISSN:1575-0922
研究方向:-
影响因子:5.551
ISSN:0307-0565
研究方向:医学-内分泌学与代谢
影响因子:0.704
ISSN:0985-0562
研究方向:医学-内分泌学与代谢
发表一篇学和医学成像类SCI论文
需要多少钱?
专注医学期刊服务15年
您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:
1.医学核心期刊发表-全流程服务
2.医学SCI期刊-全流程服务
3.论文投稿服务-快速报价
4.期刊推荐直至录用,不成功不收费
客服正在输入...
INTERNATIONAL JOURNAL OF CARDIOLOGY 投稿经验
(由下方点评分析获得,37人参与,69564人阅读)